Safety Alerts & Recalls
What does this mean?
Since dextroamphetamine has serious side effects if overdosed, this recall should be taken seriously. These side effects may include fast heart rate, high blood pressure, tremors, decreased appetite, headache, insomnia, dizziness, blurred vision, stomach upset, and dry mouth.
If you or someone you care for is taking dextroamphetamine tablets, check your bottle to find out who they were made by and if it is labeled with one of the lot numbers involved in the recall. The prescription bottle often lists the manufacturer on the pharmacy label. Or, you can look at the tablets and see if they have any of the following "ETHEX" markings:
The 10 mg Dextroamphetamine Sulfate Tablet is a round, orange tablet with "ETHEX" and "312" on one side and a double-line on the other side.
If you think your tablets are made by ETHEX Corporation you should return them to your pharmacy to examine and possibly exchange. If you are not sure who has made your tablets, please take your bottle to your pharmacist for them to check as soon as possible.
If you have any other questions about the recall or if you are experiencing side effects, you should contact your physician, pharmacist, or other health care provider. Any customer inquiries related to this recall may also be addressed to ETHEX Customer Service at 1-800-748-1472, or sent via email to: firstname.lastname@example.org with representatives available Monday through Friday, 8:00 am to 5:00 pm Central Standard Time (CST).
Recall on Several Lots of Dextroamphetamine 10 mg Tablets
The ETHEX Corporation has voluntarily recalled several lots of DEXTROAMPHETAMINE 10 mg tablets. These tablets may be oversized and contain more drug than appropriate. This could result in patients receiving as much as twice the expected dosage of this drug.
The lot numbers involved in the recall are: Dextroamphetamine Sulfate Tablets, 10 mg: Lots: 73934, 75892, 77945, 81137, 86320 with expiration dates ranging from June 2009 to May 2011
For more information, please visit: more information here